Table 3.
Evaluation of the visual results after the implantation of small-aperture intracorneal inlay.
| Author (date) | Previous history | UNVA* | UIVA* | UDVA** | Satisfaction***(%) | Postoperative complications | Explantation Yes/No (%) | Explantation reason |
|---|---|---|---|---|---|---|---|---|
| Moshirfar et al. (2018) [21] | EP | 86% | – | 88% | NR | KA | Yes (8%) | NR |
| Vukich et al. (2018) [9] | EP | 72% | 87%* | 92% | 90 (3 to 36) | CE, BDV and ST | Yes (8.7%) | CC |
| Linn et al. (2018) [23] | EP | 85% | – | 100% | NR | ↓Stereopsis 25% | No | – |
| Moshirfar et al. (2017) [22] | EP | 70% | – | NR | ↓VA, ↑IOP, DLK | Yes (8.5%) | BDV | |
| Moshirfar et. al. (2016) [24] | 64% EP, 22% PLP and 4% PPP | 44% | – | 65% | 60 (3 & 6) | None | Yes (1.8%) | HS |
| Dexl et al. (2015) [25] | EP | 74% | 87%* | 94% | 83.9 (60) | PIP, FS and ID | Yes (3.1%) | HS |
| Abbouda et al. (2014) [27] | EP | – | – | – | NR | KA and BDV | Yes (33.4%) | PIP and BDV |
| Agca et al. (2014) [14] | EP | – | – | – | NR | None | No | – |
| Huseynova et al. (2014) [26] | PPP | 46% | – | 85% | NR | NR | No | – |
| Tomita et al. (2014) [28] | EP | – | – | – | NR | None | No | – |
| Tomita and Huseynova (2014) [13] | PLP | 80% | – | 90% | NR | Infections and ED | No | – |
| Dexl et al. (2012) [10] | EP | – | – | – | NR | EG, ID and BDV. | No | – |
| Dexl et al. (2012) [17] | EP | 95% | 90%* | 100% | 75 (3–24) | KA | No | – |
| Seyeddain et al. (2013) [15] | EP | 100% | 100%* | 95% | NR | None | No | – |
| Seyeddain et al. (2012) [16] | EP | 95% | 95%* | 90% | NR | None | No | – |
| Dexl et al. (2011) [18] | EP | –- | – | – | 84.5 (3–12) | ID | No | – |
| Waring IV (2011) [19] | EP | – | – | – | 75 (NR) | None | No | – |
| Yımaz et al. (2011) [20] | EP and PLP | 96% | – | 96% | NR | None | Yes (10.3%) | Cataracts |
EP emmetropic presbyopia, PLP post-LASIK presbyopia, PPP pseudophakic presbyopia, UNVA uncorrected near visual acuity; UIVA uncorrected intermediate visual acuity, VA: visual acuity, IOP: Intraocular pressure, DLK diffuse lamellar keratitis, BV binocular vision, NR not reported, KA keratocyte activation, CE corneal oedema, BDV blur distance vision, ST stromal thinning, PIP poor implant placement, FS flap striae, ED endothelial degeneration, EG epithelial growth, ID iron deposits; CC corneal cyst, HS hyperopic shift.
*Percentage of eyes with 20/32 or better.
**Percentage of eyes with 20/25 or better.
***Include in brackets the satisfaction time collected (expressed in months).